The GLP-1 wave is upon us: 13% of Canadian households have at least one member on GLP-1s, and 18% more are open to using a GLP-1 medication in the future.

As GLP-1s reshape Canadian consumer behaviour, brands and retailers must rethink what it means to connect and win with their consumers. To accommodate strong interest from Canadian brands and retailers, we’re replaying our recent webinar featuring Numerator’s Brian Ettkin, Head of Strategy and Solutions, Canada, Dr. Leo Feler, Chief Economist, and Sid Sarin, Sr. Consumer Insights Analyst, offering a 60-minute, data-driven look at how GLP-1 adoption is influencing consumer behaviour in Canada.

This is a replay of the original session, and the content remains the same. If you were unable to attend live—or haven’t yet had the chance to watch—this replay provides an opportunity to view the full discussion, including exclusive insights from Numerator Chief Economist Dr. Feler’s proprietary research.

The session introduces Numerator’s new GLP-1 People Groups and custom analytics capabilities, designed to help brands and retailers uncover actionable insights in this fast-evolving market. We’ll cover:

• How the GLP-1 landscape is growing and changing in Canada
• Key lessons from the U.S. experience and academic research, including an exclusive conversation with Dr. Feler, whose Cornell University research on the impact of GLP-1 drugs on grocery shopping is shaping thinking across CPG, financial institutions, and academia
• Insights from Numerator’s Canadian Consulting team on early findings from Canadian data, including who new GLP-1 consumers are, what sets them apart, and how their habits are evolving
• How Numerator can help Canadian brands and retailers identify risks, opportunities, and emerging behavioural trends